Active substance:
- Feline leukemia virus (strain A/Glasgow-1), gp85 gene encoded by Venezuelan equine encephalitis virus (strain TC-83), self-amplifying RNA, viral particle, replication deficient
Route of administration:
-
Subcutaneous use
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Target species:
-
Cat
